Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

• Main Authors: Gudbjornsson B, Geirsson AJ, Krogh NS
• Format: Article in Journal/Newspaper
• Language: English
• Published: Dove Medical Press 2018
• Subjects: Psoriatic Arthritis; outcome; biological treatment; routine care; clinical nationwide registry; Dermatology; RL1-803; Steen; Iceland
• Online Access: https://doaj.org/article/1a2d9fd70fe74e35857fdaad12c0dba2

Bjorn Gudbjornsson,1,2 Arni Jon Geirsson,3,4 Niels Steen Krogh5 1Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland; 2Faculty of Medicine, University of Iceland, Reykjavik, Iceland; 3Department of Rheumatology, University Hospital, Reykjavik, Iceland; 4Laeknasetrid - Medical C...